Abstract:DNA methylation is a common epigenetic modification, characterized by the presence of the signature 5-methylcytosine without altering the sequence of DNA. The study of DNA methylation in mammals has gained significant attention due to its broad impact on numerous biological processes and its critical role in the onset and progression of many diseases, such as cancer and aging. Consequently, there is a pressing need for a rapid and precise method to assess methylation status. Currently, most approaches for quantifying DNA methylation rely on sodium bisulfite treatment. However, such approaches do not align with the uracil DNA glycosylase PCR system. In this study, we demonstrate the application of methylation-sensitive restriction enzymes (MSRE) and digital PCR to determine the methylation status of the Ras association domain family 1 isoform A (RASSF1A) in cancer cell lines. Digital PCR enables the precise detection and absolute quantification without the reliance on reference standards. We developed a multiplex digital PCR assay that includes the target gene RASSF1A, along with two reference genes for the purpose of monitoring digestion completion and correcting DNA input. Each sample of interest was measured both before and after a MSRE digestion. To ensure the quantification accuracy, we employed the commercially available CpGenome human methylated DNA standard with a known concentration from MilliporeSigma, treating it with and without a MSRE, and subsequently performing digital PCR experiments using Roche Digital LightCycler® IVD system with a Universal nanowell plate featuring 28,000 partitions. The expected concentrations lay within the 95% confidence interval, affirming the accurate quantification achieved through digital PCR. Next, we measured the fraction of methylated alleles in various lung cancer and breast cancer cell lines, as well as in healthy human gDNA. The methylation of RASSF1A promoter in healthy human gDNA is ~0.7%, while a broad range of methylation levels was observed in cancer cell lines, ranging from ~0.7% to ~100.2%. Notably, the influence of GC bias was identified in this study. To overcome this critical challenge, we optimized the usage of several high GC enhancers. The results demonstrated that the concentration of 5-7.5% DMSO, 7.5% glycerol, and commercially available OneTaq or Q5 GC enhancers from New England Biolabs were effectively incorporated into the Roche digital PCR system, thereby enhancing the accuracy of quantification from 30% to 100%. Together, we demonstrated a remarkable approach for DNA methylation analysis using Roche digital PCR system in combination with MSREs and suitable high GC enhancers. This study suggests a promising rapid, accurate and cost-effective tool to advance research in the field. *Data on file at Roche Diagnostics, Wilmington, MA, USA Citation Format: Yu Zhao, Lindsey Cambria. Quantification of DNA methylation using methylation-sensitive restriction enzymes and digital PCR [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 7009.

[Quantification of Methylation of SNCG CpG Islands in Human Tissue Samples by the Combined COBRA-DHPLC Assay].

Simultaneous Detection Of Cpg Methylation And Single Nucleotide Polymorphism By Denaturing High Performance Liquid Chromatography

Quantification of cyclooxygenase-2 methylation in gastric mucosa by denaturing high performance liquid chromatography assay

[Analysis of the Methylation in CpG Island by Denaturing High-Performance Liquid Chromatography].

Assaying DNA Methylation Based on High-Throughput Melting Curve Approaches

Detection of CPG Methylations in Human Mismatch Repair Gene Hmlh1 Promoter by Denaturing High-Performance Liquid Chromatography (DHPLC)

Methylation Status of Individual CpG Sites Within Alu Elements in the Human Genome and Alu Hypomethylation in Gastric Carcinomas

Abstract 7009: Quantification of DNA methylation using methylation-sensitive restriction enzymes and digital PCR

Combined Detection of Plasma ZIC1, HOXD10 and RUNX3 Methylation is a Promising Strategy for Early Detection of Gastric Cancer and Precancerous Lesions.

Ultrasensitive amplification-free quantification of a methyl CpG-rich cancer biomarker by single-molecule kinetic fingerprinting

Rapid Quantification of DNA Methylation by Measuring Relative Peak Heights in Direct Bisulfite-Pcr Sequencing Traces

[Screening the Differentially Methylated DNA Sequences of Colorectal Cancer by Methylated CpG Islands Amplification Coupled with Representational Difference Analysis].

Targeted DNA methylation from cell-free DNA using hybridization probe capture

Abstract 7024: Development of quality control methods for reliable NGS measurement of methylation in cfDNA

Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning

A novel methyl-dependent DNA endonuclease GlaI coupling with double cascaded strand displacement amplification and CRISPR/Cas12a for ultra-sensitive detection of DNA methylation

Methylation-specific Electrochemical Biosensing Strategy for Highly Sensitive and Quantitative Analysis of Promoter Methylation of Tumor-Suppressor Gene in Real Sample

Quantification of methylated markers with a multiplex methylation-specific technology

Quantitative Methylation Analysis of Multiple Genes Using Methylation-Sensitive Restriction Enzyme-Based Quantitative PCR for the Detection of Hepatocellular Carcinoma.

Evaluating methylation of human ribosomal DNA at each CpG site reveals its utility for cancer detection using cell-free DNA

Aberrant methylation scanning by quantitative DNA melting analysis with hybridization probes as exemplified by liquid biopsy of SEPT9 and HIST1H4F in colorectal cancer